Mostafa Samiul, Tagboto Senyo, Robinson Michael, Burden Andrew, Davies Simon
Department of Nephrology, University Hospital of North Staffordshire, Princes Road, Hartshill, Stoke-on-Trent ST4 7LN, UK.
Fam Pract. 2009 Jun;26(3):180-2. doi: 10.1093/fampra/cmp009. Epub 2009 Mar 2.
AIMS. Anaemia is a complication of chronic kidney disease (CKD); the National Institute for Clinical Excellence (NICE) have defined renal anaemia as estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 and haemoglobin (HB) <11.0 g/dl. The purpose of this study was to see if diabetic patients have a higher prevalence in primary care of this new anaemia definition. Furthermore, we wished to determine whether diabetic patients were over-represented above HB 11.0 g/dl, which may lead to developing renal anaemia.
We used an observational prevalence study in primary care from one Staffordshire practice in 2005-2006. Egton Medical Information Systems Ltd computer database was searched for patients with two Modification of Diet in Renal Disease eGFRs separated by 3 months, HB levels and medications.
From a list size of 1830 patients, 362 had two eGFRs <60; of those, 308 had a HB available. In all, 29 (9.4%) patients had NICE renal anaemia, with over-representation of diabetic patients, 13 (16%) against 16 (7%) without diabetes (P < 0.02). We found that diabetic patients were also over-represented at HB 11.0 to <12.5 g/dl, 26 (32%) with diabetes and 39 (17.6%) without (P < 0.001). Mean HB was significantly lower for the diabetic group (n = 81, 26%), 12.8 g/dl (95% Confidence Intervals (CI) 12.4-13.1) against non-diabetic group (n = 227, 74%), 13.4 g/dl (95% CI 13.2-13.6), P < 0.01. Predictors of HB on multivariate regression analysis were female gender, eGFR and diabetes (all P < 0.001).
Diabetic patients were more likely to have NICE defined renal anaemia in this primary care population with CKD stages 3-5. This is similar to observations in secondary care settings. We observed over-representation of diabetic patients above NICE definition at HB 11.0 to <12.5 g/dl.
目的。贫血是慢性肾脏病(CKD)的一种并发症;英国国家卫生与临床优化研究所(NICE)将肾性贫血定义为估算肾小球滤过率(eGFR)<60 ml/min/1.73 m²且血红蛋白(HB)<11.0 g/dl。本研究的目的是观察糖尿病患者在初级医疗中符合这一新贫血定义的患病率是否更高。此外,我们希望确定糖尿病患者在血红蛋白水平高于11.0 g/dl时是否占比过高,这可能会导致肾性贫血的发生。
我们在2005 - 2006年对斯塔福德郡一家医疗机构的初级医疗进行了一项观察性患病率研究。在埃格顿医疗信息系统有限公司的计算机数据库中搜索有两次间隔3个月的肾病饮食改良估算肾小球滤过率、血红蛋白水平及用药情况的患者。
在1830名患者名单中,362人有两次估算肾小球滤过率<60;其中,308人有血红蛋白数据。总共有29名(9.4%)患者患有NICE定义的肾性贫血,糖尿病患者占比过高,13名(16%)糖尿病患者,16名(7%)非糖尿病患者(P < 0.02)。我们发现糖尿病患者在血红蛋白水平为11.0至<12.5 g/dl时也占比过高,26名(32%)糖尿病患者,39名(17.6%)非糖尿病患者(P < 0.001)。糖尿病组(n = 81,26%)的平均血红蛋白水平显著低于非糖尿病组(n = 227,74%),分别为12.8 g/dl(95%置信区间(CI)12.4 - 13.1)和13.4 g/dl(95% CI 13.2 - 13.6),P < 0.01。多因素回归分析中血红蛋白的预测因素为女性性别、估算肾小球滤过率和糖尿病(均P < 0.001)。
在这一患有3 - 5期CKD的初级医疗人群中,糖尿病患者更有可能患有NICE定义的肾性贫血。这与二级医疗环境中的观察结果相似。我们观察到糖尿病患者在血红蛋白水平高于NICE定义(11.0至<12.5 g/dl)时占比过高。